XCUR
Price
$11.13
Change
-$0.12 (-1.07%)
Updated
Apr 24 closing price
Capitalization
70.35M
XFOR
Price
$0.19
Change
-$0.01 (-5.00%)
Updated
Apr 24 closing price
Capitalization
32.51M
13 days until earnings call
Ad is loading...

XCUR vs XFOR

Header iconXCUR vs XFOR Comparison
Open Charts XCUR vs XFORBanner chart's image
Exicure
Price$11.13
Change-$0.12 (-1.07%)
Volume$13.33K
Capitalization70.35M
X4 Pharmaceuticals
Price$0.19
Change-$0.01 (-5.00%)
Volume$2.84M
Capitalization32.51M
XCUR vs XFOR Comparison Chart
Loading...
XCUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
XCUR vs. XFOR commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is XCUR is a Buy and XFOR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (XCUR: $11.14 vs. XFOR: $0.19)
Brand notoriety: XCUR and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: XCUR: 38% vs. XFOR: 170%
Market capitalization -- XCUR: $70.35M vs. XFOR: $32.51M
XCUR [@Biotechnology] is valued at $70.35M. XFOR’s [@Biotechnology] market capitalization is $32.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

XCUR’s FA Score shows that 0 FA rating(s) are green whileXFOR’s FA Score has 0 green FA rating(s).

  • XCUR’s FA Score: 0 green, 5 red.
  • XFOR’s FA Score: 0 green, 5 red.
According to our system of comparison, both XCUR and XFOR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

XCUR’s TA Score shows that 4 TA indicator(s) are bullish while XFOR’s TA Score has 5 bullish TA indicator(s).

  • XCUR’s TA Score: 4 bullish, 6 bearish.
  • XFOR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, XFOR is a better buy in the short-term than XCUR.

Price Growth

XCUR (@Biotechnology) experienced а +31.93% price change this week, while XFOR (@Biotechnology) price change was -1.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

XCUR is expected to report earnings on Aug 13, 2024.

XFOR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XCUR($70.3M) has a higher market cap than XFOR($32.5M). XFOR has higher P/E ratio than XCUR: XFOR (3.10) vs XCUR (0.19). XCUR YTD gains are higher at: -18.544 vs. XFOR (-74.482). XCUR has higher annual earnings (EBITDA): -3.17M vs. XFOR (-7.74M). XFOR has more cash in the bank: 135M vs. XCUR (343K). XCUR has less debt than XFOR: XCUR (6.13M) vs XFOR (78.2M). XFOR has higher revenues than XCUR: XFOR (1.12M) vs XCUR (500K).
XCURXFORXCUR / XFOR
Capitalization70.3M32.5M216%
EBITDA-3.17M-7.74M41%
Gain YTD-18.544-74.48225%
P/E Ratio0.193.106%
Revenue500K1.12M45%
Total Cash343K135M0%
Total Debt6.13M78.2M8%
FUNDAMENTALS RATINGS
XCUR vs XFOR: Fundamental Ratings
XCUR
XFOR
OUTLOOK RATING
1..100
5057
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9693
PRICE GROWTH RATING
1..100
3496
P/E GROWTH RATING
1..100
10087
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XFOR's Valuation (40) in the Biotechnology industry is in the same range as XCUR (71) in the null industry. This means that XFOR’s stock grew similarly to XCUR’s over the last 12 months.

XFOR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as XCUR (100) in the null industry. This means that XFOR’s stock grew similarly to XCUR’s over the last 12 months.

XFOR's SMR Rating (93) in the Biotechnology industry is in the same range as XCUR (96) in the null industry. This means that XFOR’s stock grew similarly to XCUR’s over the last 12 months.

XCUR's Price Growth Rating (34) in the null industry is somewhat better than the same rating for XFOR (96) in the Biotechnology industry. This means that XCUR’s stock grew somewhat faster than XFOR’s over the last 12 months.

XFOR's P/E Growth Rating (87) in the Biotechnology industry is in the same range as XCUR (100) in the null industry. This means that XFOR’s stock grew similarly to XCUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
XCURXFOR
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
XCUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPI33.133.19
+10.65%
Intrepid Potash
ADPT7.890.51
+6.91%
Adaptive Biotechnologies Corp
NCTY12.680.62
+5.14%
The9 Limited
NEM55.702.55
+4.80%
Newmont Corp
UBSI34.46-0.01
-0.03%
United Bankshares

XCUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XCUR has been loosely correlated with XFOR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XCUR jumps, then XFOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XCUR
1D Price
Change %
XCUR100%
-1.11%
XFOR - XCUR
34%
Loosely correlated
-7.00%
ALNY - XCUR
26%
Poorly correlated
+0.26%
NNVC - XCUR
25%
Poorly correlated
+1.23%
PLX - XCUR
25%
Poorly correlated
-0.68%
KRYS - XCUR
24%
Poorly correlated
+2.00%
More

XFOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with IMMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then IMMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
-7.00%
IMMP - XFOR
37%
Loosely correlated
+3.70%
XCUR - XFOR
34%
Loosely correlated
-1.11%
SPHDF - XFOR
34%
Loosely correlated
N/A
LRMR - XFOR
31%
Poorly correlated
+4.87%
CRDF - XFOR
30%
Poorly correlated
-1.36%
More